Blue Cross Blue Shield of Texas - Medicare Part D Updates

Pharmacy
Preferred Drug List
Injectable Drug Program
Rx List & Prescribing Guidelines
Quantity vs Time
Override Request Form (pdf - 11k)
Step Therapy/Prior Authorization Forms
Topical Verapamil Override Request Form (pdf - 13k)

Medicare Part D Updates

Please review the following content as a convenient repository of Medicare Part D-related information.

Medicare Part D Updates
2009
	Extended release Niacin vs. Ezetimibe: Results of the ARBITER 6-HALTS Trial - November 2009
	Formulary Changes 2009 to 2010 - November 2009
	Dose Optimization - October 2009
	FDA Advisory Committee Considers New Warnings and Proposed Changes to Acetaminophen Products - September 2009
	FDA Takes Action to Ensure Safe Use of Propoxyphene Containing Products - August 2009
	TARCEVA (erlotinib) Safety Alert - June 2009
	RAPTIVA (efalizumab) Withdrawn from Market - June 2009
	2010 Call Letter - April 2009
	Formulary Updates - 1st Quarter 2009
	The JUPITER Trial - January 2009
2008
	Formulary Changes - 2008 to 2009
	Increased Risk of Death With Antipsychotic Drug Treatment for Dementia - November 2008
	Medicare Part D Formulary Changes - 2008 to 2009
	Increased Risk of Death With Antipsychotic Drug Treatment for Dementia - November 2008
	State Prescription and Monitoring Programs - October 2008
	Formulary Updates - 3rd Q 2008
	National Transition from Chlorofluorocarbon (CFC) Propelled Albuterol Inhalers to Hydrofluroalkane (HFA) Propelled Albuterol Inhalers, August 2008
	Formulary Updates - 2nd Q 2008
	Updates on Medication Recalls - June 2008
	Formulary Updates - 1st Q 2008
	Medicare Therapy Management Program - Prime Therapeutics - April 2008
	Inappropriate Use of Fentanyl Transdermal (DURAGESIC) Patches! - February 2008
	Strategies to Avoid Medicare’s Part D Coverage Gap - January 2008
2007
	Overlapping Coverage between Part B and Part D Drugs - November 2007